Evidence map›Paper›PMID 41002030›Full record

ArticleNucleic acids research2025

Coordinated control of genome-nuclear lamina interactions by topoisomerase 2B and lamin B receptor.

Tom van Schaik, Mikhail Magnitov, Marcel de Haas, Jeremie Breda, Elzo de Wit, Anna G Manjon, René H Medema, Henrike Johanna Gothe, Vassilis Roukos, Adam J Buckle and 4 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The Roles of Topoisomerases in Transcriptional Regulation.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tom van SchaikDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Mikhail MagnitovDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Marcel de HaasDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Jeremie BredaDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Elzo de WitDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0003-2883-1415
Anna G ManjonDivision of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
René H MedemaDivision of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0009-0004-3701-7751
Henrike Johanna GotheInstitute of Molecular Biology gGmbH, 55128 Mainz, Germany.
Vassilis RoukosInstitute of Molecular Biology gGmbH, 55128 Mainz, Germany.
Adam J BuckleInstitute of Genetics and Cancer, MRC Human Genetics Unit, The University of Edinburgh, EH4 1QY Edinburgh.
Catherine NaughtonInstitute of Genetics and Cancer, MRC Human Genetics Unit, The University of Edinburgh, EH4 1QY Edinburgh.
Nick GilbertInstitute of Genetics and Cancer, MRC Human Genetics Unit, The University of Edinburgh, EH4 1QY Edinburgh.ORCID 0000-0003-0505-6081
Bas van SteenselDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-0284-0404
Stefano G ManzoDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-6911-3527

Funding

Deutsche Forschungsgemeinschaft 393547839SFB 1361Deutsche Forschungsgemeinschaft 402733153-SPP 2202Deutsche Forschungsgemeinschaft 455784893Dutch Cancer SocietyEU-MUR MSCA Young Researcher MSCA_000020European Union 694466European Union 800924European Union 838555European Union 865459European Union MSCA_000020MRC MC_UU_00007/13NWO 58588UK Medical Research Council MR/J00913X/1
6 · The paper itself

Abstract

Lamina-associated domains (LADs) are megabase-sized genomic regions anchored to the nuclear lamina (NL). Factors controlling the interactions of the genome with the NL have largely remained elusive. Here, we identified DNA topoisomerase 2 beta (TOP2B) as a regulator of these interactions. TOP2B binds predominantly to inter-LAD (iLAD) chromatin and its depletion results in a partial loss of genomic partitioning between LADs and iLADs, suggesting that this enzyme might protect specific iLADs from interacting with the NL. TOP2B depletion affects LAD interactions with lamin B receptor (LBR) more than with lamins. LBR depletion phenocopies the effects of TOP2B depletion, despite the different positioning of the two proteins in the genome. This suggests a complementary mechanism for organizing the genome at the NL. Indeed, co-depletion of TOP2B and LBR causes partial LAD/iLAD inversion, reflecting changes typical of oncogene-induced senescence. We propose that a coordinated axis controlled by TOP2B in iLADs and LBR in LADs maintains the partitioning of the genome between the NL and the nuclear interior.

Indexed as

DNA Topoisomerases, Type IIGenome, HumanNuclear LaminaReceptors, Cytoplasmic and NuclearChromatinHumansLamin B ReceptorPoly-ADP-Ribose Binding ProteinsProtein BindingChromatinDNA Topoisomerases, Type IILamin B ReceptorPoly-ADP-Ribose Binding ProteinsReceptors, Cytoplasmic and NuclearTOP2B protein, human

Identifiers

PMID41002030
PMCPMC12464825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.